Financial Year 2024: Weleda Achieves Record Turnover and Significantly Improves Profitability
1 Articles
1 Articles
Financial Year 2024: Weleda Achieves Record Turnover and Significantly Improves Profitability
Turnover increased by 8.3% to EUR 456.2 million. Operating profit (EBIT excluding special effects) more than doubled from EUR 13.4 million to EUR 28.3 million. Both business units – Natural Cosmetics and Pharmaceuticals – delivered strong growth worldwide. Strategic growth drivers: internationalisation, digitalisation, innovation, and premiumisation. CEO Tina Müller: “2024 was a year of renewal for Weleda – and a very strong year for us economic…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage